2021. [Endolymphatic use of drug preparations in the treatment of malignant tumors of the lymphatic system].2022. [A comparative analysis of the antiblastic and immunodepressive effect of alkylating agents].2023. [The effect of various doses of nitrosomethyl (ethyl) urea on the development of spontaneous leukosis and tumors in mice].2024. [Antineoplastic effect of the antibiotics rubomycin B and C in experimental conditions].2025. [The use of tumor cells for the primary screening of antineoplastic antibiotics].2026. [Comparison of tauromycetin with red-violet indicator antibiotics].2027. [Characteristics of the action of medicinal substances on the fetus at various periods of intrauterine development].2028. [Various methods of applying cytostatic agents in the form of shock therapy in the prevention of metastasis and relapse of tumors].2029. [Chemotherapy in papillomatosis of the respiratory tract].2030. [The anti-tumor activity of 5-di(2-chlorethyl)amino DL-tryptophan].2031. [Experience of use of bruneomycin in leukemia].2032. [The efficacy of intralymphatic use of antiblastic drugs].2033. [The hypoplastic state of hematopoiesis following chemotherapy with alkylating compounds].2034. [On intra-arterial chemotherapy of stomach cancer].2035. [Various aspects of the problem of selectivity in the chemotherapy of cancer].2036. [On bacteremia in patients with malignant ovarian neoplasms].2038. [Present state and perspectives concerning the medical treatment of cancer].2039. [Study of sensitivity to antibiotics in cultures of Anacystis nidulans and Chlorella sp. in relation to their possible use as tests in selection of new biologically active compounds from Actinomycetes].2040. [The blood coagulation and anticoagulant systems of the blood in the chemo-surgical treatment of lung cancer]. |